Case-Based Inference of Avacopan’s Impact on Renal Inflammation and Tissue damage in ANCA-associated Vasculitis Patients

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/64fe5031a0afa46f7ada176b01ef26fa.pdf
Case-Based Inference of Avacopan’s Impact on Renal Inflammation and Tissue damage in ANCA-associated Vasculitis Patients

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Tomomi
Endo
Tomomi Endo tsujiit40@gmail.com Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Nephrology and Dialysis Osaka Japan *
Yui Fukuda imokempifukuda@gmail.com Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Nephrology and Dialysis Osaka Japan - Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Nephorology Nagoya Japan
Miho Miyauchi mihomiyauchi0319@gmail.com Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Nephrology and Dialysis Osaka Japan - Shiga University of Medical Science Nephrology and Diabetes Otsu Japan
Kaoru Ohue k-ooue@kitano-hp.or.jp Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Nephrology and Dialysis Osaka Japan -
Seigi Oshima seigi4oshima9jc@gmail.com Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Hematology Osaka Japan -
Tatsuo Tsukamoto tsukamoto5017@gmail.com Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Nephrology and Dialysis Osaka Japan -
Takeshi Matsubara mtake@kuhp.kyoto-u.ac.jp Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Nephrology and Dialysis Osaka Japan -
Eri Muso emuso@kki.biglobe.ne.jp Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai Nephrology and Dialysis Osaka Japan - Faculty of Contemporary Life Studies, Kyoto Kacho University Food and Nutrition Kyoto Japan